Health Care Archives - Page 40 of 478

2 minute read

Sanofi’s Multiple Sclerosis Antibody Shows Reduction Of Disease Activity

April 17, 11:37 AM

Discover results from Sanofi's Phase 2 study on frexalimab for relapsing multiple sclerosis. Explore sustained reduction in disease activity and lesion numbers with low relapse rates.

SNY

2 minute read

Eli Lilly’s Famed Weight Loss Drug Zepbound Works As Sleep Apnea Treatment, Successful Late-Stage Studies Show

By Vandana Singh

April 17, 8:59 AM

Goundbreaking results in treating obstructive sleep apnea (OSA) with Eli Lilly's tirzepatide. See significant reductions in apnea-hypopnea index (AHI) and body weight, offering hope for OSA patients.

LLY

1 minute read

Abbott Labs Q1 Revenue Jumps On Strong Medical Devices Sales, Company Boosts Annual Guidance

By Vandana Singh

April 17, 8:42 AM

Abbott Laboratories surpasses expectations with Q1 sales hitting $9.96B, a 10.8% rise driven by robust performance in Medical Devices, Established Pharmaceuticals, Nutrition, and Diagnostics. CEO Robert Ford boosts full-year sales outlook amidst strong Q1 growth.

ABT

2 minute read

GSK Says Its Blockbuster Shingles Vaccine Shows High Efficacy Even After 10 Years

By Vandana Singh

April 17, 8:06 AM

Lasting protection against shingles for adults over 50 with GSK's RZV vaccine. New data from ZOSTER-049 trial reveals over a decade of high efficacy. Plus, GSK's oral antibiotic, gepotidacin, shows promising results for uncomplicated gonorrhea treatment.

GSK

2 minute read

Avalo Therapeutics’ Newly Acquired Ex-Eli Lilly Drug Could Stand Out In Competitive Hidradenitis Suppurativa Market, Analyst Upgrades

By Vandana Singh

April 16, 2:25 PM

Unlock the potential of Avalo Therapeutics with AVTX-009, a promising drug for hidradenitis suppurativa. Oppenheimer upgrades to Outperform, foreseeing Phase 2 progress and market distinction.

ABBV

1 minute read

UnitedHealth’s Q1 Medical Cost Update, Prudent Outlook Eases Investor Concerns: Goldman Sachs

By Vandana Singh

April 16, 2:03 PM

UnitedHealth impresses with Q1 results amid the aftermath of the Change Healthcare cyberattack and maintains strong guidance amidst business disruption costs. Goldman Sachs reaffirms Buy rating, citing favorable medical cost updates and prudent outlook, despite cyberattack-related challenges.

UNH

2 minute read

Cullinan Shifts Focus From Oncology To Autoimmune Disorders, Raises $280M Via Equity

By Vandana Singh

April 16, 1:32 PM

Cullinan shifts focus to autoimmune diseases with CLN-978, targeting systemic lupus erythematosus. Initial trial results show potential for treatment with a differentiated safety profile.

CGEM

2 minute read

Intra-Cellular Stock Rallies On Successful Late-Stage Depression Treatment Study

By Vandana Singh

April 16, 12:13 PM

Unlock new hope for major depressive disorder with Lumateperone 42 mg. Results from Intra-Cellular's Study 501, show significant symptom relief as adjunctive therapy to antidepressants.

ITCI

2 minute read

IGC Pharma Says Cannabinoid-Based Drug Candidate Provides Fast Relief With Fewer Side Effects For Alzheimer’s-Associated Agitation

By Vandana Singh

April 16, 11:47 AM

IGC Pharma shares encouraging interim data from Phase 2 trial of IGC-AD1 for Alzheimer's agitation. Results suggest significant reduction in agitation with minimal side effects compared to placebo.

IGC

2 minute read

Johnson & Johnson Q1 Earnings Tops Wall Street Estimates On Strong Medical Devices Sales, Boosts Annual Outlook

By Vandana Singh

April 16, 9:29 AM

Johnson & Johnson reports Q1 results: adjusted EPS $2.71 (up 12.4% Y/Y), sales $21.38B (up 2.3% Y/Y). Explore pharma giant's robust performance, including strong growth in Innovative Medicine and medical devices sales.

JNJ